Enginprime Medical raises $12M
Enginprime Medical announced a Series A round of $12M on 18 August 2026. The company operates in HealthTech and is based in China. It was founded by Zhiyong Liu, CEO.
Founder
Zhiyong Liu
CEO, Enginprime Medical
Outreach angles
- -Enginprime Medical was founded in 2023 by Voyagers Capital as a dedicated venture to build next-generation ventricular assist devices.
- -CEO Zhiyong Liu is steering the company's flagship OpusOne device through China's national regulatory trial process.
- -The Series A funding from Qiming Venture Partners will move OpusOne into registration clinical trials in China ahead of global submissions.
Signals
Series AHealthcareDeep TechHardwareRegulated Industry
Round details
Company: Enginprime Medical
Domain: enginprime.com
Amount: $12M
Stage: Series A
Industry: HealthTech
Country: China
Announced: 18 August 2026
Other HealthTech raises
Recently funded in China